• Your Trusted Usenet Provider
  • Secure, Private, Unlimited

Newsgroups Main » Newsgroups Directory » Science and Technology » Psychology

Psychotherapy ( sci.psychology.psychotherapy )
 
From [email protected] Wed May 15 18:55:52 1996
Path: uunet!bounce-back
From: John Grohol <[email protected]>
Newsgroups: news.announce.newgroups,news.groups,sci.psychology.psychotherapy,sci.psychology.misc
Subject: RFD: sci.psychology.psychotherapy moderated
Followup-To: news.groups
Date: 15 May 1996 22:55:56 -0000
Organization: .
Lines: 207
Sender: [email protected]
Approved: [email protected]
Message-ID: <[email protected]>
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.psychology.psychotherapy
Xref: uunet news.announce.newgroups:8688 news.groups:206568 sci.psychology.psychotherapy:9770 sci.psychology.misc:7124

                     REQUEST FOR DISCUSSION (RFD)
             moderated group sci.psychology.psychotherapy

This is a formal Request For Discussion (RFD) for the change in
status from unmoderated to moderated for the Usenet newsgroup,
sci.psychology.psychotherapy. This is not a Call for Votes (CFV);
you cannot vote at this time.  Procedural details are below.

Newsgroup line:
sci.psychology.psychotherapy	Practice of psychotherapy. (Moderated)

RATIONALE: sci.psychology.psychotherapy

Since this newsgroup was created a year ago, it has acted as a
dumping ground for any miscellaneous article an author feels is
appropriate, without regard to the group's charter. Instead of
becoming a niche for professionals and laypeople alike to discuss
psychotherapy techniques and similar topics, it has become a foggy
mirror of sci.psychology.misc, hosting discussions on topics ranging
from sex with children to the ever-popular scientology topics.
Personal e-mail, changing followups in threads, and posting the
charter on a regular basis has done little to dissuade the
off-charter topics that regularly appear and overwhelm the newsgroup.

Individuals, too, have used this and similar groups as a soap-box
in which to preach their particular gripes against psychotherapy,
or more generally, science and psychology. While certainly criticism
of psychotherapy is appropriate to this forum, dozens of articles
posted every day from the same people also are overwhelming the
group's ability to sustain and propose other appropriate topics.
Dozens of professionals who have contacted me in the past year
have stated their desire to utilize the forum for discussions of
psychotherapy topics, but are fearful to do so because of the flames
and personal insults they have observed on it.

It is therefore proposed to moderate this newsgroup with a broad
range of moderators, to help reduce the overwhelming noise on
the group and bring it closer to the intentions of the original
charter.

CHARTER: sci.psychology.psychotherapy

This newsgroup is for the discussion of all different modalities of
psychotherapy, their efficacy, and their acceptance within the
psychotherapeutic community. All forms of psychotherapy as
practiced by a wide range of disciplines (psychology, psychiatry,
marriage and family counseling, social work, etc.) are
welcomed here, as are all clinicians in varying fields. Emphasis
is placed on discussing psychotherapeutic methods, rather than
research or theory, since these latter topics are covered in separate
newsgroups.

Examples of appropriate topics for this newsgroup might be discussion
of techniques used in interpersonal therapy, cognitive-behavioral
therapy, psychoanalysis, psychodynamic therapy, marriage and family
therapy, client-centered therapy, rational-emotive therapy, etc.
Ethical issues in practice as well as specific psychotherapeutic
techniques may also be discussed. Case discussions, as long as
anonymity is ensured, are also welcome. Participants are reminded
always to be careful of confidentiality and ethical issues when
posting such questions.

Individuals seeking help or information on a specific emotional,
psychological or related physical problem or disorder
may also post questions about specifical psychotherapeutic
techniques and treatments. Individuals are encouraged, however,
to seek out answers to these types of questions elsewhere first.

Advertisements for any products, as well as discussions on:
psychopharamalogical interventions, whether psychology is a
"science" or not, scientology topics, whether X behavior is
"normal" or not, and on any research or theoretical areas
outside the purview of psychology or psychotherapy would remain
on other existing newsgroups and are examples of topics that are
inappropriate for this group. "Flaming" and personal insults are
also not appropriate to this newsgroup.

Moderation Guidelines:

This is a loosely moderated group, moderation mainly being
used to screen out irrelevant, non-psycotherapy articles, personal
attacks and arguments, irrelevant political debate, and other
topics as warranted.

The purpose of moderation on sci.psychology.psychotherapy
is create a collegial forum for the discussion about
psychotherapy -- in all forms and as practiced by any clinician.
For purposes of moderation, psychotherapy is used in a broad
sense.  It includes the discussion of topics that overlap with
other academic disciplines along with nontraditional areas and
approaches to psychotherapy. Similarly, "related issues" and
"applications" are defined broadly.

Moderation of sci.psychology.psychotherapy is not the Usenet
equivalent of editing a journal; it is meant to work as a filter.
The moderation is conducted in a spirit of inclusiveness and
collegiality.  Authors are encouraged to keep the content of their
articles directed toward applications of psychotherapy.  Authors
are also encouraged to cite relevant references in the literature
or provide some documentation for claims when and if possible.
When disagreeing with another poster, authors are encouraged to
concentrate on the others' ideas.

Submission Guidelines:

Articles should be checked for spelling and
  formatted with a line length of less than 72 columns,
  or else they will be automatically rejected. Articles
  will be edited for length and clarity.

Articles will also be automatically rejected if they are
  crossposted to non-psychology related newsgroups. Please
  resubmit the article and post it only to sci.psychology.psychotherapy
  and other sci.psychology newsgroups if this happens.

Articles requesting a literature search or references
  on a given topic will automatically be rejected out of
  hand, unless it is shown such a search has already
  been done and was fruitless. This includes the typical
  "Does anybody know anything about topic X?" or "Where
  do I look for information on topic Y?" The answer, of
  course, is in your local library.

Followups-To: and Reply-To: headers
  will be set to the appropriate address or newsgroup
  at the moderator's discretion.

If accepted, the article will be posted to
  sci.psychology.psychotherapy in a couple of days.
  (Please be patient.)

Since most articles are written and sent to us
  through newsreaders and various mail transports
  across the Internet, it is recommended that authors
  hold onto a copy of their submitted article in case of loss.

If the article is not accepted, a moderator
  will notify you of the rejection and give a brief
  explanation of why it was not accepted. Articles
  can be resubmitted for further consideration.

If an author would like a resubmission to be
  considered by the entire set of moderators, it
  should be noted in the mail to moderator.  If the
  majority of the moderators approve of the article,
  it will be posted in a couple of days.

Threads may be terminated and/or new articles may
  be rejected on these threads if there are many
  submissions saying essentially the same thing.
  Specifically, if an article has 80% or more same
  content as a previously-approved article which was
  posted in the past 30 days, it will be rejected.

Any person who _repeatedly_ abuses the
  charter, the group, the moderators, netiquette,
  etc., will not have articles approved,
  regardless of the content, until they can show
  good cause that they have changed their behaviors
  to conform to this charter.

END CHARTER.

MODERATOR INFO: sci.psychology.psychotherapy

Moderator: Rolf Lindgren <[email protected]>
Moderator: Paul Bernhardt <[email protected]>
Moderator: Phil Cremer <[email protected]>
Moderator: Mike Rael <[email protected]>
Moderator: John Grohol <[email protected]>

This moderation team is preliminary and changes may be
made during the RFD process.

END MODERATOR INFO.

PROCEDURE:

This is a request for discussion, not a call for votes.  In this phase
of the process, any potential problems with the proposed newsgroups
should be raised and resolved.  The discussion period will continue
for a minimum of 21 days (starting from when the first RFD for this
proposal is posted to news.announce.newgroups), after which a Call For
Votes (CFV) may be posted by a neutral vote taker if the discussion
warrants it.  Please do not attempt to vote until this happens.

All discussion of this proposal should be posted to news.groups.

This RFD attempts to comply fully with the Usenet newsgroup creation
guidelines outlined in "How to Create a New Usenet Newsgroup" and "How
to Format and Submit a New Group Proposal".  Please refer to these
documents (available in news.announce.newgroups) if you have any
questions about the process.

DISTRIBUTION:

  news.announce.newgroups, news.groups,
  sci.psychology.psychotherapy, sci.psychology.announce,
  sci.psychology.misc


-
Proponent: John M. Grohol, Psy.D. <[email protected]>

-- 
Behavior OnLine                                       Mental Health Net
http://www.behavior.net/                           http://www.cmhc.com/

From [email protected] Fri May 24 16:12:31 1996
Path: uunet!bounce-back
From: John Grohol <[email protected]>
Newsgroups: news.announce.newgroups,news.groups,sci.psychology.psychotherapy,sci.psychology.misc,sci.psychology.announce
Subject: 2nd RFD: sci.psychology.psychotherapy moderated
Followup-To: news.groups
Date: 24 May 1996 20:12:45 -0000
Organization: .
Lines: 237
Sender: [email protected]
Approved: [email protected]
Message-ID: <[email protected]>
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.psychology.psychotherapy
Xref: uunet news.announce.newgroups:8726 news.groups:207846 sci.psychology.psychotherapy:10490 sci.psychology.misc:7293 sci.psychology.announce:429

                     REQUEST FOR DISCUSSION (RFD)
             moderated group sci.psychology.psychotherapy

This is the second formal Request For Discussion (RFD) for the change
in status from unmoderated to moderated for the Usenet newsgroup,
sci.psychology.psychotherapy. This is not a Call for Votes (CFV);
you cannot vote at this time.  Procedural details are below.

Newsgroup line:
sci.psychology.psychotherapy	Practice of psychotherapy. (Moderated)

CHANGES SINCE THE 1st RFD: sci.psychology.psychotherapy

Where appropriate, changes since the 1st RFD are noted by
asterisks. A summary of these changes follows:

1. A rationale was added for moderating the existing group
   over adding an additional newsgroup on the same topic.
2. Two new tentative moderators were added to the moderation
   team.
3. Psychpharmacology was removed as an objectionable
   topic in the charter and is now considered an appropriate
   topic for discussion in the proposed newsgroup.
4. Submission guidelines were edited for clarity, to ensure that
   it is understood that the proposed moderation is to be "loose."
   Specific changes include reducing the ability to edit a submission
   before approving it, removing objectionable language, reducing
   power of moderators to act individually or in an abusive manner to
   censor one poster, making acceptance criteria more liberal and
   clarified editing guidelines and language.


RATIONALE: sci.psychology.psychotherapy

Since this newsgroup was created a year ago, it has acted as a
dumping ground for any miscellaneous article an author feels is
appropriate, without regard to the group's charter. Instead of
becoming a niche for professionals and laypeople alike to discuss
psychotherapy techniques and similar topics, it has become a foggy
mirror of sci.psychology.misc, hosting discussions on topics ranging
from sex with children to the ever-popular scientology topics.
Personal e-mail, changing followups in threads, and posting the
charter on a regular basis has done little to dissuade the
off-charter topics that regularly appear and overwhelm the newsgroup.

Individuals, too, have used this and similar groups as a soap-box
in which to preach their particular gripes against psychotherapy,
or more generally, science and psychology. While certainly criticism
of psychotherapy is appropriate to this forum, dozens of articles
posted every day from the same people also are overwhelming the
group's ability to sustain and propose other appropriate topics.
Dozens of professionals who have contacted me in the past year
have stated their desire to utilize the forum for discussions of
psychotherapy topics, but are fearful to do so because of the flames
and personal insults they have observed on it.

It is therefore proposed to moderate this newsgroup with a broad
range of moderators, to help reduce the overwhelming noise on
the group and bring it closer to the intentions of the original
charter.

* An additional newsgroup for discussion of psychotherapy topics
* does not appear warranted at this time, given the relatively low
* volume of articles on sci.psychology.psychotherapy
* (less than 200 per day) and its relative age (created less than
* a year ago). No current topics on sci.psychology.psychotherapy
* which discuss psychotherapy or therapy in general would
* appear to be inappropriate to the proposed moderated version
* of the newsgroup, according to the revised charter below.


CHARTER: sci.psychology.psychotherapy

This newsgroup is for the discussion of all different modalities of
psychotherapy, their efficacy, and their acceptance within the
psychotherapeutic and broader worldwide community.
All forms of psychotherapy as practiced by a wide range
of disciplines (psychology, psychiatry,
marriage and family counseling, social work, etc.) are
welcomed here, as are all clinicians in varying fields. Emphasis
is placed on discussing psychotherapeutic methods, rather than
research or theory, since these latter topics are covered in separate
newsgroups. However, research and theory discussions related
to psychotherapy and psychotherapeutic methods are welcomed.

Examples of appropriate topics for this newsgroup might be discussion
of techniques used in interpersonal therapy, cognitive-behavioral
therapy, psychoanalysis, psychodynamic therapy, marriage and family
therapy, client-centered therapy, rational-emotive therapy, etc.
* Psychopharmacology topics are also appropriate to this newsgroup,
* in relation to a broader discussion on aspects of mental health treatment.
Ethical issues in practice as well as specific psychotherapeutic
techniques may also be discussed. Case discussions, as long as
anonymity is ensured, are also welcome. Participants are reminded
always to be careful of confidentiality and ethical issues when
posting such questions.

Individuals seeking help or information on a specific emotional,
psychological or related physical problem or disorder
may also post questions about specifical psychotherapeutic
techniques and treatments. Individuals are encouraged, however,
to seek out answers to these types of questions elsewhere first.

Advertisements for any products, whether psychology is a
"science" or not, scientology topics, whether X behavior is
"normal" or not, and on any research or theoretical areas
outside the purview of psychology or psychotherapy would remain
on other existing newsgroups and are examples of topics that are
inappropriate for this group. "Flaming" and personal insults are
also not appropriate to this newsgroup.

Moderation Guidelines:

* This is a loosely moderated group, moderation mainly being
* used to screen out irrelevant, non-psychotherapy articles, personal
* attacks, ad hominem arguments and irrelevant political debate.

The purpose of moderation on sci.psychology.psychotherapy
is to create a collegial forum for the discussion about
psychotherapy -- in all forms and as practiced by any clinician.
For purposes of moderation, psychotherapy is used in a broad
sense.  It includes the discussion of topics that overlap with
other academic disciplines along with nontraditional areas and
approaches to psychotherapy. Similarly, "related issues" and
"applications" are defined broadly.

Moderation of sci.psychology.psychotherapy is not the Usenet
equivalent of editing a journal; it is meant to work as a filter.
The moderation is conducted in a spirit of inclusiveness and
collegiality.  Authors are encouraged to keep the content of their
articles directed toward applications of psychotherapy.  Authors
are also encouraged to cite relevant references in the literature
or provide some documentation for claims when and if possible.
When disagreeing with another poster, authors are encouraged to
concentrate on the others' ideas.

Submission Guidelines:

Articles should be checked for spelling and
  formatted with a line length of less than 72 columns.
*   Articles may occasionally undergo *minor* editing
*   for punctuation, subject header, etc. Any significant
*   changes to the content of an article will not occur,
*   without prior approval and permission from the
*   original author. Followup-To: and Reply-To: headers
  will be set to the appropriate address or newsgroup
  at the moderator's discretion.

Articles may be automatically rejected if they are
  crossposted to non-psychology related newsgroups.
*   Please resubmit the article and post it only to
*   sci.psychology.psychotherapy and other psychology
*   or relevant mental health newsgroups if this occurs.

If accepted, the article will be posted to
  sci.psychology.psychotherapy in a couple of days.
  (Please be patient and do not resubmit the article.)
  Since most articles are written and sent to the
  moderators through newsreaders and various mail
  transports across the Internet, it is recommended
  that authors hold onto a copy of their submitted
  article in case of accidental loss.

If the article is not accepted, a moderator
  will notify you of the rejection and give a brief
  explanation of why it was not accepted. Articles
  can be resubmitted for further consideration.
  If an author would like a resubmission to be
  considered by the entire set of moderators, it
  should be noted in the e-mail to the moderator.
*   If a simple majority of the moderators then approve
*   the article, it will be immediately posted.

* Articles which have 80% or more same content as a
*   previously-approved article by the same author
*   (not including quoted material) which was
*   posted in the past 30 days will be rejected.
*   Authors are encouraged to trim quoted material of
*   articles to which they are replying, to highlight the
*   relevant points in the quoted material.
*
* Abuse of the moderation process in the form of
*   mail-bombs, personal threats, etc. will result
*   in the abuser's Internet service provider being
*   notified. Additional action(s) may be taken if
*   the moderators unanimously agree additional
*   action(s) are necessary and warranted.


END CHARTER.

MODERATOR INFO: sci.psychology.psychotherapy

* Moderator: Ember Beck <[email protected]> (Tentative)
* Moderator: Dan L. Rogers <[email protected]> (Tentative)
Moderator: Rolf Lindgren <[email protected]>
Moderator: Paul Bernhardt <[email protected]>
Moderator: Phil Cremer <[email protected]>
Moderator: Mike Rael <[email protected]>
Moderator: John Grohol <[email protected]>

This moderation team is preliminary and changes may be
made during the RFD process.

END MODERATOR INFO.

PROCEDURE:

This is the second request for discussion, not a call for votes.  In this phase
of the process, any potential problems with the proposed newsgroups
should be raised and resolved.  The discussion period will continue
for a minimum of 21 days (starting from when the first RFD for this
proposal is posted to news.announce.newgroups), after which a Call For
Votes (CFV) may be posted by a neutral vote taker if the discussion
warrants it.  Please do not attempt to vote until this happens.

All discussion of this proposal should be posted to news.groups.

This RFD attempts to comply fully with the Usenet newsgroup creation
guidelines outlined in "How to Create a New Usenet Newsgroup" and "How
to Format and Submit a New Group Proposal".  Please refer to these
documents (available in news.announce.newgroups) if you have any
questions about the process.

DISTRIBUTION:

  news.announce.newgroups, news.groups,
  sci.psychology.psychotherapy, sci.psychology.announce,
  sci.psychology.misc


-
Proponent: John M. Grohol, Psy.D. <[email protected]>

-- 
Behavior OnLine                                       Mental Health Net
http://www.behavior.net/                           http://www.cmhc.com/

From [email protected] Fri Jun 21 14:30:41 1996
Path: uunet!bounce-back
From: Jani Patokallio <[email protected]>
Newsgroups: news.announce.newgroups,news.groups,sci.psychology.announce,sci.psychology.misc,sci.psychology.psychotherapy
Subject: CFV: moderate sci.psychology.psychotherapy
Followup-To: poster
Date: 21 Jun 1996 18:31:17 -0000
Organization: Usenet Volunteer Votetakers
Lines: 236
Sender: [email protected]
Approved: [email protected]
Expires: 13 Jul 1996 00:00:00 GMT
Message-ID: <[email protected]>
Reply-To: [email protected]
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.psychology.psychotherapy
Xref: uunet news.announce.newgroups:8889 news.groups:213064 sci.psychology.announce:482 sci.psychology.misc:7657 sci.psychology.psychotherapy:12470

                     FIRST CALL FOR VOTES (of 2)
moderated group sci.psychology.psychotherapy (moderates existing group)

Newsgroups line:
sci.psychology.psychotherapy	Practice of psychotherapy. (Moderated)

Votes must be received by 23:59:59 UTC, 12 Jul 1996.

This vote is being conducted by a neutral third party.  Questions
about the proposed group should be directed to the proponent.

Proponent: John M. Grohol <[email protected]>
Votetaker: Jani Patokallio <[email protected]>

RATIONALE: sci.psychology.psychotherapy

Since this newsgroup was created less than a year ago, it has acted as a
dumping ground for any miscellaneous article an author feels is
appropriate, without regard to the group's charter. Instead of
becoming a niche for professionals and laypeople alike to discuss
psychotherapy techniques and similar topics, it has become a foggy
mirror of sci.psychology.misc, hosting discussions on topics ranging
from sex with children to the ever-popular scientology topics.

Individuals, too, have used this and similar groups as a soap-box
in which to preach their particular gripes against psychotherapy,
or more generally, science and psychology. While certainly criticism
of psychotherapy is appropriate to this forum, dozens of articles
posted every day from the same people also are overwhelming the
group's ability to sustain and propose other appropriate topics.
Dozens of professionals who have contacted me in the past year
have stated their desire to utilize the forum for discussions of
psychotherapy topics, but are fearful to do so because of the flames
and personal insults they have observed on it.

It is therefore proposed to moderate this newsgroup with a broad
range of moderators, to help reduce the overwhelming noise on
the group and bring it closer to the intentions of the original
charter.

An additional newsgroup for discussion of psychotherapy topics
does not appear warranted at this time, given the relatively low
volume of articles on sci.psychology.psychotherapy
(less than 200 per day) and its relative age (created less than
a year ago). No current topics on sci.psychology.psychotherapy
which discuss psychotherapy or therapy in general would
appear to be inappropriate to the proposed moderated version
of the newsgroup.

CHARTER: sci.psychology.psychotherapy

This newsgroup is for the discussion of all different modalities of
psychotherapy, their efficacy, and their acceptance within the
psychotherapeutic and broader worldwide community.
All forms of psychotherapy as practiced by a wide range
of disciplines (psychology, psychiatry,
marriage and family counseling, social work, etc.) are
welcomed here, as are all clinicians in varying fields. Emphasis
is placed on discussing psychotherapeutic methods, rather than
research or theory, since these latter topics are covered in separate
newsgroups. However, research and theory discussions related
to psychotherapy and psychotherapeutic methods are welcomed.

Examples of appropriate topics for this newsgroup might be discussion
of techniques used in interpersonal therapy, cognitive-behavioral
therapy, psychoanalysis, psychodynamic therapy, marriage and family
therapy, client-centered therapy, rational-emotive therapy, etc.
Psychopharmacology topics are also appropriate to this newsgroup,
in relation to a broader discussion on aspects of mental health treatment.
Ethical issues in practice as well as specific psychotherapeutic
techniques may also be discussed. Case discussions, as long as
anonymity is ensured, are also welcome. Participants are reminded
always to be careful of confidentiality and ethical issues when
posting such questions.

Individuals seeking help or information on a specific emotional,
psychological or related physical problem or disorder
may also post questions about specifical psychotherapeutic
techniques and treatments. Individuals are encouraged, however,
to seek out answers to these types of questions elsewhere first.

Advertisements for any products, whether psychology is a
"science" or not, scientology topics, whether X behavior is
"normal" or not, and on any research or theoretical areas
outside the purview of psychology or psychotherapy would remain
on other existing newsgroups and are examples of topics that are
inappropriate for this group. "Flaming" and personal insults are
also not appropriate to this newsgroup.

Moderation Guidelines:

This is a loosely moderated group, moderation mainly being
used to screen out irrelevant, non-psychotherapy articles, personal
attacks, ad hominem arguments and irrelevant political debate.

The purpose of moderation on sci.psychology.psychotherapy
is to create a collegial forum for the discussion about
psychotherapy -- in all forms and as practiced by any clinician.
For purposes of moderation, psychotherapy is used in a broad
sense.  It includes the discussion of topics that overlap with
other academic disciplines along with nontraditional areas and
approaches to psychotherapy. Similarly, "related issues" and
"applications" are defined broadly.

Moderation of sci.psychology.psychotherapy is not the Usenet
equivalent of editing a journal; it is meant to work as a filter.
The moderation is conducted in a spirit of inclusiveness and
collegiality.  Authors are encouraged to keep the content of their
articles directed toward applications of psychotherapy.  Authors
are also encouraged to cite relevant references in the literature
or provide some documentation for claims when and if possible.
When disagreeing with another poster, authors are encouraged to
concentrate on the others' ideas.

Submission Guidelines:

Articles should be checked for spelling and
  formatted with a line length of less than 72 columns.
  Articles may occasionally undergo *minor* editing
  for punctuation, subject header, etc. Any significant
  changes to the content of an article will not occur,
  without prior approval and permission from the
  original author. Followup-To: and Reply-To: headers
  will be set to the appropriate address or newsgroup
  at the moderator's discretion.

Articles may be automatically rejected if they are
  crossposted to non-psychology related newsgroups.
  Please resubmit the article and post it only to
  sci.psychology.psychotherapy and other psychology
  or relevant mental health newsgroups if this occurs.

If accepted, the article will be posted to
  sci.psychology.psychotherapy in a couple of days.
  (Please be patient and do not resubmit the article.)
  Since most articles are written and sent to the
  moderators through newsreaders and various mail
  transports across the Internet, it is recommended
  that authors hold onto a copy of their submitted
  article in case of accidental loss.

If the article is not accepted, a moderator
  will notify you of the rejection and give a brief
  explanation of why it was not accepted. Articles
  can be resubmitted for further consideration.
  If an author would like a resubmission to be
  considered by the entire set of moderators, it
  should be noted in the e-mail to the moderator.
  If a simple majority of the moderators then approve
  the article, it will be immediately posted.

Articles which have 75-80% or more same content as a
  previously-approved article by the same author
  (not including quoted material) which was
  posted in the past 30 days will be rejected.
  Authors are encouraged to trim quoted material of
  articles to which they are replying, to highlight the
  relevant points in the quoted material.

Abuse of the moderation process in the form of
  mail-bombs, personal threats, etc. will result
  in the abuser's Internet service provider being
  notified. Additional action(s) may be taken if
  the moderators unanimously agree additional
  action(s) are necessary and warranted.

Changes to moderators, including removing and adding
  new moderators, will be determined at a later date
  by the moderators in consultation with the newsgroup.

END CHARTER.

MODERATOR INFO: sci.psychology.psychotherapy

Moderator: "Vance E. Lear" <[email protected]>
Moderator: Ember Beck <[email protected]>
Moderator: Rolf Lindgren <[email protected]>
Moderator: Mike Rael <[email protected]>
Moderator: John Grohol <[email protected]>
Administrative contact address: [email protected]
Article submission address: [email protected]

END MODERATOR INFO.

HOW TO VOTE:

Follow these instructions *exactly*!  Votes are counted by computer.
You should send E-MAIL (posts to a newsgroup are invalid) to:

    [email protected]

Please do not assume that just replying to this message will work.
Check the address before you mail your vote.  Your mail message
should contain one and only one of the following vote statements:

    I vote YES on sci.psychology.psychotherapy
    I vote NO on sci.psychology.psychotherapy

    Voter name:

If your mail software does not indicate your real name (for example, AOL and
Delphi do not), include _exactly_ the statement above on a _separate_ line
and add your name after the colon.  Having your name in your signature line
is NOT enough!  Do NOT join the lines together or remove the words
"Voter name"!

You may also vote ABSTAIN (which does exactly that) or CANCEL (which
removes any earlier votes).  ABSTAIN does not affect the final vote count
in any way but is listed, whereas CANCEL is not.

IMPORTANT VOTING PROCEDURE NOTES:

Standard Guidelines for voting apply.  One person, one vote.  Votes
must be mailed directly from the voter to the votetaker.  Anonymous,
forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI
forms are considered to be anonymous votes.

Vote counting is automated.  Failure to follow these directions may
mean that your vote does not get counted.  If you do not receive an
acknowledgment of your vote within three days contact the votetaker
about the problem.  It's your responsibility to make sure your vote
is registered correctly.  Duplicate votes are resolved in favor of
the most recent valid vote.  Addresses and votes of all voters will
be published in the final voting results post.

The purpose of a Usenet vote is to determine the genuine interest of
persons who would read a proposed newsgroup.  Soliciting votes from
disinterested parties defeats this purpose.  Please do not distribute
this CFV.  If you must, direct people to the official CFV as posted
to news.announce.newgroups.  Distributing pre-marked or otherwise
edited copies of this CFV is generally considered to be vote fraud.
When in doubt, ask the votetaker.

-- 
Jani Patokallio <[email protected]>
Voting address: <[email protected]>

From [email protected] Sun Jun 30 03:29:59 1996
Path: uunet!bounce-back
From: Jani Patokallio <[email protected]>
Newsgroups: news.announce.newgroups,news.groups,sci.psychology.announce,sci.psychology.misc,sci.psychology.psychotherapy
Subject: 2nd CFV: moderate sci.psychology.psychotherapy
Supersedes: <[email protected]>
Followup-To: poster
Date: 30 Jun 1996 07:30:24 -0000
Organization: Usenet Volunteer Votetakers
Lines: 236
Sender: [email protected]
Approved: [email protected]
Expires: 13 Jul 1996 00:00:00 GMT
Message-ID: <[email protected]>
Reply-To: [email protected]
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.psychology.psychotherapy
Xref: uunet news.announce.newgroups:8908 news.groups:214722 sci.psychology.announce:493 sci.psychology.misc:7905 sci.psychology.psychotherapy:12908

                      LAST CALL FOR VOTES (of 2)
moderated group sci.psychology.psychotherapy (moderates existing group)

Newsgroups line:
sci.psychology.psychotherapy	Practice of psychotherapy. (Moderated)

Votes must be received by 23:59:59 UTC, 12 Jul 1996.

This vote is being conducted by a neutral third party.  Questions
about the proposed group should be directed to the proponent.

Proponent: John M. Grohol <[email protected]>
Votetaker: Jani Patokallio <[email protected]>

RATIONALE: sci.psychology.psychotherapy

Since this newsgroup was created less than a year ago, it has acted as a
dumping ground for any miscellaneous article an author feels is
appropriate, without regard to the group's charter. Instead of
becoming a niche for professionals and laypeople alike to discuss
psychotherapy techniques and similar topics, it has become a foggy
mirror of sci.psychology.misc, hosting discussions on topics ranging
from sex with children to the ever-popular scientology topics.

Individuals, too, have used this and similar groups as a soap-box
in which to preach their particular gripes against psychotherapy,
or more generally, science and psychology. While certainly criticism
of psychotherapy is appropriate to this forum, dozens of articles
posted every day from the same people also are overwhelming the
group's ability to sustain and propose other appropriate topics.
Dozens of professionals who have contacted me in the past year
have stated their desire to utilize the forum for discussions of
psychotherapy topics, but are fearful to do so because of the flames
and personal insults they have observed on it.

It is therefore proposed to moderate this newsgroup with a broad
range of moderators, to help reduce the overwhelming noise on
the group and bring it closer to the intentions of the original
charter.

An additional newsgroup for discussion of psychotherapy topics
does not appear warranted at this time, given the relatively low
volume of articles on sci.psychology.psychotherapy
(less than 200 per day) and its relative age (created less than
a year ago). No current topics on sci.psychology.psychotherapy
which discuss psychotherapy or therapy in general would
appear to be inappropriate to the proposed moderated version
of the newsgroup.

CHARTER: sci.psychology.psychotherapy

This newsgroup is for the discussion of all different modalities of
psychotherapy, their efficacy, and their acceptance within the
psychotherapeutic and broader worldwide community.
All forms of psychotherapy as practiced by a wide range
of disciplines (psychology, psychiatry,
marriage and family counseling, social work, etc.) are
welcomed here, as are all clinicians in varying fields. Emphasis
is placed on discussing psychotherapeutic methods, rather than
research or theory, since these latter topics are covered in separate
newsgroups. However, research and theory discussions related
to psychotherapy and psychotherapeutic methods are welcomed.

Examples of appropriate topics for this newsgroup might be discussion
of techniques used in interpersonal therapy, cognitive-behavioral
therapy, psychoanalysis, psychodynamic therapy, marriage and family
therapy, client-centered therapy, rational-emotive therapy, etc.
Psychopharmacology topics are also appropriate to this newsgroup,
in relation to a broader discussion on aspects of mental health treatment.
Ethical issues in practice as well as specific psychotherapeutic
techniques may also be discussed. Case discussions, as long as
anonymity is ensured, are also welcome. Participants are reminded
always to be careful of confidentiality and ethical issues when
posting such questions.

Individuals seeking help or information on a specific emotional,
psychological or related physical problem or disorder
may also post questions about specifical psychotherapeutic
techniques and treatments. Individuals are encouraged, however,
to seek out answers to these types of questions elsewhere first.

Advertisements for any products, whether psychology is a
"science" or not, scientology topics, whether X behavior is
"normal" or not, and on any research or theoretical areas
outside the purview of psychology or psychotherapy would remain
on other existing newsgroups and are examples of topics that are
inappropriate for this group. "Flaming" and personal insults are
also not appropriate to this newsgroup.

Moderation Guidelines:

This is a loosely moderated group, moderation mainly being
used to screen out irrelevant, non-psychotherapy articles, personal
attacks, ad hominem arguments and irrelevant political debate.

The purpose of moderation on sci.psychology.psychotherapy
is to create a collegial forum for the discussion about
psychotherapy -- in all forms and as practiced by any clinician.
For purposes of moderation, psychotherapy is used in a broad
sense.  It includes the discussion of topics that overlap with
other academic disciplines along with nontraditional areas and
approaches to psychotherapy. Similarly, "related issues" and
"applications" are defined broadly.

Moderation of sci.psychology.psychotherapy is not the Usenet
equivalent of editing a journal; it is meant to work as a filter.
The moderation is conducted in a spirit of inclusiveness and
collegiality.  Authors are encouraged to keep the content of their
articles directed toward applications of psychotherapy.  Authors
are also encouraged to cite relevant references in the literature
or provide some documentation for claims when and if possible.
When disagreeing with another poster, authors are encouraged to
concentrate on the others' ideas.

Submission Guidelines:

Articles should be checked for spelling and
  formatted with a line length of less than 72 columns.
  Articles may occasionally undergo *minor* editing
  for punctuation, subject header, etc. Any significant
  changes to the content of an article will not occur,
  without prior approval and permission from the
  original author. Followup-To: and Reply-To: headers
  will be set to the appropriate address or newsgroup
  at the moderator's discretion.

Articles may be automatically rejected if they are
  crossposted to non-psychology related newsgroups.
  Please resubmit the article and post it only to
  sci.psychology.psychotherapy and other psychology
  or relevant mental health newsgroups if this occurs.

If accepted, the article will be posted to
  sci.psychology.psychotherapy in a couple of days.
  (Please be patient and do not resubmit the article.)
  Since most articles are written and sent to the
  moderators through newsreaders and various mail
  transports across the Internet, it is recommended
  that authors hold onto a copy of their submitted
  article in case of accidental loss.

If the article is not accepted, a moderator
  will notify you of the rejection and give a brief
  explanation of why it was not accepted. Articles
  can be resubmitted for further consideration.
  If an author would like a resubmission to be
  considered by the entire set of moderators, it
  should be noted in the e-mail to the moderator.
  If a simple majority of the moderators then approve
  the article, it will be immediately posted.

Articles which have 75-80% or more same content as a
  previously-approved article by the same author
  (not including quoted material) which was
  posted in the past 30 days will be rejected.
  Authors are encouraged to trim quoted material of
  articles to which they are replying, to highlight the
  relevant points in the quoted material.

Abuse of the moderation process in the form of
  mail-bombs, personal threats, etc. will result
  in the abuser's Internet service provider being
  notified. Additional action(s) may be taken if
  the moderators unanimously agree additional
  action(s) are necessary and warranted.

Changes to moderators, including removing and adding
  new moderators, will be determined at a later date
  by the moderators in consultation with the newsgroup.

END CHARTER.

MODERATOR INFO: sci.psychology.psychotherapy

Moderator: "Vance E. Lear" <[email protected]>
Moderator: Ember Beck <[email protected]>
Moderator: Rolf Lindgren <[email protected]>
Moderator: Mike Rael <[email protected]>
Moderator: John Grohol <[email protected]>
Administrative contact address: [email protected]
Article submission address: [email protected]

END MODERATOR INFO.

HOW TO VOTE:

Follow these instructions *exactly*!  Votes are counted by computer.
You should send E-MAIL (posts to a newsgroup are invalid) to:

    [email protected]

Please do not assume that just replying to this message will work.
Check the address before you mail your vote.  Your mail message
should contain one and only one of the following vote statements:

    I vote YES on moderating sci.psychology.psychotherapy
    I vote NO on moderating sci.psychology.psychotherapy

    Voter name:

If your mail software does not indicate your real name (for example, AOL and
Delphi do not), include _exactly_ the statement above on a _separate_ line
and add your name after the colon.  Having your name in your signature line
is NOT enough!  Do NOT join the lines together or remove the words
"Voter name"!

You may also vote ABSTAIN (which does exactly that) or CANCEL (which
removes any earlier votes).  ABSTAIN does not affect the final vote count
in any way but is listed, whereas CANCEL is not.

IMPORTANT VOTING PROCEDURE NOTES:

Standard Guidelines for voting apply.  One person, one vote.  Votes
must be mailed directly from the voter to the votetaker.  Anonymous,
forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI
forms are considered to be anonymous votes.

Vote counting is automated.  Failure to follow these directions may
mean that your vote does not get counted.  If you do not receive an
acknowledgment of your vote within three days contact the votetaker
about the problem.  It's your responsibility to make sure your vote
is registered correctly.  Duplicate votes are resolved in favor of
the most recent valid vote.  Addresses and votes of all voters will
be published in the final voting results post.

The purpose of a Usenet vote is to determine the genuine interest of
persons who would read a proposed newsgroup.  Soliciting votes from
disinterested parties defeats this purpose.  Please do not distribute
this CFV.  If you must, direct people to the official CFV as posted
to news.announce.newgroups.  Distributing pre-marked or otherwise
edited copies of this CFV is generally considered to be vote fraud.
When in doubt, ask the votetaker.

-- 
Jani Patokallio <[email protected]>
Voting address: <[email protected]>

From [email protected] Sat Jul 13 02:49:53 1996
Path: uunet!bounce-back
From: Jani Patokallio <[email protected]>
Newsgroups: news.announce.newgroups,news.groups,sci.psychology.announce,sci.psychology.misc,sci.psychology.psychotherapy
Subject: RESULT: moderate sci.psychology.psychotherapy fails 125:48
Supersedes: <[email protected]>
Followup-To: news.groups
Date: 13 Jul 1996 02:49:35 -0400
Organization: Usenet Volunteer Votetakers
Lines: 391
Sender: [email protected]
Approved: [email protected]
Message-ID: <[email protected]>
Reply-To: [email protected]
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.psychology.psychotherapy
Xref: uunet news.announce.newgroups:8943 news.groups:217094 sci.psychology.announce:512 sci.psychology.misc:8179 sci.psychology.psychotherapy:13382

                                RESULT
moderated group sci.psychology.psychotherapy (moderates existing group) fails 125:48

There were 125 YES votes and 48 NO votes, for a total of 173 valid votes.
There were 2 abstains and 2 invalid ballots.

For group passage, YES votes must be at least 2/3 of all valid (YES and NO)
votes.   There also must be at least 100 more YES votes than NO votes.

There is a five day discussion period after these results are posted.
Unless serious allegations of voting irregularities are raised, the group may
not be voted on again for six months.

Newsgroups line:
sci.psychology.psychotherapy	Practice of psychotherapy. (Moderated)

The voting period closed at 23:59:59 UTC, 12 Jul 1996.

This vote was conducted by a neutral third party.  Questions
about the proposed group should be directed to the proponent.

Proponent: John M. Grohol <[email protected]>
Votetaker: Jani Patokallio <[email protected]>

RATIONALE: sci.psychology.psychotherapy

Since this newsgroup was created less than a year ago, it has acted as a
dumping ground for any miscellaneous article an author feels is
appropriate, without regard to the group's charter. Instead of
becoming a niche for professionals and laypeople alike to discuss
psychotherapy techniques and similar topics, it has become a foggy
mirror of sci.psychology.misc, hosting discussions on topics ranging
from sex with children to the ever-popular scientology topics.

Individuals, too, have used this and similar groups as a soap-box
in which to preach their particular gripes against psychotherapy,
or more generally, science and psychology. While certainly criticism
of psychotherapy is appropriate to this forum, dozens of articles
posted every day from the same people also are overwhelming the
group's ability to sustain and propose other appropriate topics.
Dozens of professionals who have contacted me in the past year
have stated their desire to utilize the forum for discussions of
psychotherapy topics, but are fearful to do so because of the flames
and personal insults they have observed on it.

It is therefore proposed to moderate this newsgroup with a broad
range of moderators, to help reduce the overwhelming noise on
the group and bring it closer to the intentions of the original
charter.

An additional newsgroup for discussion of psychotherapy topics
does not appear warranted at this time, given the relatively low
volume of articles on sci.psychology.psychotherapy
(less than 200 per day) and its relative age (created less than
a year ago). No current topics on sci.psychology.psychotherapy
which discuss psychotherapy or therapy in general would
appear to be inappropriate to the proposed moderated version
of the newsgroup.

CHARTER: sci.psychology.psychotherapy

This newsgroup is for the discussion of all different modalities of
psychotherapy, their efficacy, and their acceptance within the
psychotherapeutic and broader worldwide community.
All forms of psychotherapy as practiced by a wide range
of disciplines (psychology, psychiatry,
marriage and family counseling, social work, etc.) are
welcomed here, as are all clinicians in varying fields. Emphasis
is placed on discussing psychotherapeutic methods, rather than
research or theory, since these latter topics are covered in separate
newsgroups. However, research and theory discussions related
to psychotherapy and psychotherapeutic methods are welcomed.

Examples of appropriate topics for this newsgroup might be discussion
of techniques used in interpersonal therapy, cognitive-behavioral
therapy, psychoanalysis, psychodynamic therapy, marriage and family
therapy, client-centered therapy, rational-emotive therapy, etc.
Psychopharmacology topics are also appropriate to this newsgroup,
in relation to a broader discussion on aspects of mental health treatment.
Ethical issues in practice as well as specific psychotherapeutic
techniques may also be discussed. Case discussions, as long as
anonymity is ensured, are also welcome. Participants are reminded
always to be careful of confidentiality and ethical issues when
posting such questions.

Individuals seeking help or information on a specific emotional,
psychological or related physical problem or disorder
may also post questions about specifical psychotherapeutic
techniques and treatments. Individuals are encouraged, however,
to seek out answers to these types of questions elsewhere first.

Advertisements for any products, whether psychology is a
"science" or not, scientology topics, whether X behavior is
"normal" or not, and on any research or theoretical areas
outside the purview of psychology or psychotherapy would remain
on other existing newsgroups and are examples of topics that are
inappropriate for this group. "Flaming" and personal insults are
also not appropriate to this newsgroup.

Moderation Guidelines:

This is a loosely moderated group, moderation mainly being
used to screen out irrelevant, non-psychotherapy articles, personal
attacks, ad hominem arguments and irrelevant political debate.

The purpose of moderation on sci.psychology.psychotherapy
is to create a collegial forum for the discussion about
psychotherapy -- in all forms and as practiced by any clinician.
For purposes of moderation, psychotherapy is used in a broad
sense.  It includes the discussion of topics that overlap with
other academic disciplines along with nontraditional areas and
approaches to psychotherapy. Similarly, "related issues" and
"applications" are defined broadly.

Moderation of sci.psychology.psychotherapy is not the Usenet
equivalent of editing a journal; it is meant to work as a filter.
The moderation is conducted in a spirit of inclusiveness and
collegiality.  Authors are encouraged to keep the content of their
articles directed toward applications of psychotherapy.  Authors
are also encouraged to cite relevant references in the literature
or provide some documentation for claims when and if possible.
When disagreeing with another poster, authors are encouraged to
concentrate on the others' ideas.

Submission Guidelines:

Articles should be checked for spelling and
  formatted with a line length of less than 72 columns.
  Articles may occasionally undergo *minor* editing
  for punctuation, subject header, etc. Any significant
  changes to the content of an article will not occur,
  without prior approval and permission from the
  original author. Followup-To: and Reply-To: headers
  will be set to the appropriate address or newsgroup
  at the moderator's discretion.

Articles may be automatically rejected if they are
  crossposted to non-psychology related newsgroups.
  Please resubmit the article and post it only to
  sci.psychology.psychotherapy and other psychology
  or relevant mental health newsgroups if this occurs.

If accepted, the article will be posted to
  sci.psychology.psychotherapy in a couple of days.
  (Please be patient and do not resubmit the article.)
  Since most articles are written and sent to the
  moderators through newsreaders and various mail
  transports across the Internet, it is recommended
  that authors hold onto a copy of their submitted
  article in case of accidental loss.

If the article is not accepted, a moderator
  will notify you of the rejection and give a brief
  explanation of why it was not accepted. Articles
  can be resubmitted for further consideration.
  If an author would like a resubmission to be
  considered by the entire set of moderators, it
  should be noted in the e-mail to the moderator.
  If a simple majority of the moderators then approve
  the article, it will be immediately posted.

Articles which have 75-80% or more same content as a
  previously-approved article by the same author
  (not including quoted material) which was
  posted in the past 30 days will be rejected.
  Authors are encouraged to trim quoted material of
  articles to which they are replying, to highlight the
  relevant points in the quoted material.

Abuse of the moderation process in the form of
  mail-bombs, personal threats, etc. will result
  in the abuser's Internet service provider being
  notified. Additional action(s) may be taken if
  the moderators unanimously agree additional
  action(s) are necessary and warranted.

Changes to moderators, including removing and adding
  new moderators, will be determined at a later date
  by the moderators in consultation with the newsgroup.

END CHARTER.

MODERATOR INFO: sci.psychology.psychotherapy

Moderator: "Vance E. Lear" <[email protected]>
Moderator: Ember Beck <[email protected]>
Moderator: Rolf Lindgren <[email protected]>
Moderator: Mike Rael <[email protected]>
Moderator: John Grohol <[email protected]>
Administrative contact address: [email protected]
Article submission address: [email protected]

END MODERATOR INFO.

sci.psychology.psychotherapy (moderates existing group) Final Vote Ack

Voted Yes
------------------------------------------------------------------------------
[email protected]                                                    D Renard
[email protected]                                    Rosemarie Ventura
[email protected]                                                        Akita Inus
[email protected]                                                 Alex Rogowski
[email protected]                                 Nancy Alvarado, Ph.D.
[email protected]                                                   Vincent Archer
[email protected]                                Margrit Wurzer
[email protected]                                         Stephanie da Silva
[email protected]
[email protected]                                                 Kelly Harvey
[email protected]                                     Beverly Barbato
[email protected]                                                    Beth Soucar
[email protected]                                                   Shag
[email protected]                                    Debra A Bottjen
[email protected]                                                  Cheryl Martin
[email protected]                                  Kent A. Campbell, PhD
[email protected]    Carolyn E. Davidson, Ph.D., Clinical Psychologist, Tenne
[email protected]                                Herve Choplin
[email protected]
[email protected]                                                James Grohol
[email protected]                                       david (d.c.) cromwell
[email protected]                                      Christopher Grala, Psy.D.
[email protected]                                          Dave JW Day
[email protected]                                                     David Brom
[email protected]                                               Daniel Fulton
[email protected]                                     Dan L. Rogers
[email protected]                                     Don McCreary
[email protected]                                                  Vance E. Lear
[email protected]                                             Laura Dolson
[email protected]                                                  Don Kiely
[email protected]                                                     Larry Tout
[email protected]                                                    David Shaw
[email protected]                                                 David Wolff
[email protected]                                         Ed Anderson
[email protected]                                         Asikaa P Cosgrove
[email protected]                                                Richard Ellis
[email protected]                                                   Ember Beck
[email protected]                                   Eric G. Myers
[email protected]                                                Eric Sandrich
[email protected]                                                  Eric Scharff
[email protected]                                               Frank Fujita
[email protected]                                    David Fresco
[email protected]                                       Gerhard Luecke
[email protected]                                             Gordon Trockman MD
[email protected]                                                    John Grohol
[email protected]                                                 Frank Harper
[email protected]                                                    Bill Harrar
[email protected]                                           Hirsch Davis
[email protected]                                              Will Hester
[email protected]                                     [email protected]
[email protected]                                      Ian Jackson
[email protected]                                                    Jay Lapidus
[email protected]                                                    Jamie Eimermann
[email protected]                                                Jennifer Saad
[email protected]
[email protected]                                 Jeffrey S. Kline
[email protected]                                              JASON RENAUD
[email protected]                                                 John Sproule
[email protected]                              Judi Lapsley Miller
[email protected]                                          Juerg Huber
[email protected]                                Jonathan Vaughan
[email protected]                                             Jason Willoughby
[email protected]                                     Karl H. Kischkel
[email protected]                   Koenraad G. F. Janssens
[email protected]                                          Michael Steven Rael
[email protected]                                   Lance K. Chun
[email protected]
[email protected]                                                Mick Brown
[email protected]                                                   Lisa Green
[email protected]                                                   Lila Hanft
[email protected]                                          Margaret Crosby
[email protected]                                                         Mark Atwood
[email protected]                                          Marie Louise Bratt
[email protected]                                                    Mike Fessler
[email protected]                                           Michele Jean
[email protected]                                              Mike Forrest
[email protected]                                               Michel Landry
[email protected]                          Martin Mikoleit(Bielefeld, Germany)
[email protected]                                   Mikko Taneli Oilinki
[email protected]                                                 Madeleine Page
[email protected]                                             Myron Pulier
[email protected]                                       Christian Weisgerber
[email protected]                                           Heidi NAGEL
[email protected]                                              Ho-Leung Ng
[email protected]                                           Nick Gassman
[email protected]                               Olle Lindevall
[email protected]                                        P.Lucas
[email protected]                                    Paul Bernhardt
[email protected]                                              Trevor Tymchuk
[email protected]                                       Flavio Macchietto
[email protected]                                          Peter Hood
[email protected]                                                Patrick Hublou
[email protected]                   Dipl.-Psych. Juergen A. Reiss
[email protected]
[email protected]                                                  Edward Reid
[email protected]                                    Rick Ellison
[email protected]                                      Caroline Malmgren-Davis
[email protected]                                           Richard B. Woods
[email protected]                                             Richard H. Miller
[email protected]                                      Rebecca McQuitty
[email protected]                                            Randall Dederick
[email protected]                                         Olavi Noronen
[email protected]                                             Stan Cooper
[email protected]                                                 Simon Grant
[email protected]                                                  Doug Sheppard
[email protected]                                         Norman Perlmutter
[email protected]                                            George McCoy
[email protected]                                         Daniel L. Snyder
[email protected]                                              Larry C. Lyons
[email protected]                                               Stan Townsend
[email protected]                                               Tammy Segraves
[email protected]                                                   Tony Basoglu
[email protected]                                                 Tim McNamara
[email protected]                                                Bruce Tindall
[email protected]                                                       Terry Knab
[email protected]                                                Todd C. Lawson
[email protected]                                                   J. Topasna
[email protected]                                                  Terry
[email protected]                                          Charles Vance
[email protected]                                     Laurie Sheerer
[email protected]                                     Werner Unbekannt
[email protected]                                          Matthew Galloucis
[email protected]                                           Steve Arlow
[email protected]                                                   Jeffrey M. Odom
[email protected]                                  Paul Repacholi

Voted No
------------------------------------------------------------------------------
[email protected]                                      Maria Vansuelos
[email protected]                                                      Ann Date
[email protected]                                                Anna McDonnell
[email protected]                                            Randy Skelton
[email protected]                                                    Art Stone
[email protected]                                     W.E. (Bill) Goodrich, PhD
[email protected]                                             Martin H. Booda
[email protected]                                                  brad jesness
[email protected]                                                     Ales Casar
[email protected]                                                 Carl Goodrich
[email protected]                                             Clark Ross
[email protected]                                   Christopher Lodge Stamper
[email protected]                                        Jeffrey N. Browndyke
[email protected]                                                Dudley Ames
[email protected]                                                    Don Ballard
[email protected]                                             David L. Hanson
[email protected]                                         Dave Vinson
[email protected]                                             Andrew C Robertson
[email protected]                                       Franz Fehringer
[email protected]                                      Jerry McClurg
[email protected]                                          Geoffrey Moore
[email protected]                                                  John Clark.
[email protected]                                               Jiho Sargent
[email protected]                                           John M Price, PhD
[email protected]                                                Fred Cherry
[email protected]                                                John Leslie
[email protected]                                              Kim DeVaughn
[email protected]                                                       Lee Lady
[email protected]                                                    Larry Smith
[email protected]                                           Marilyn Geiger
[email protected]                                       Michael Cook
[email protected]                                             Olav Nieuwejaar
[email protected]                                                  Paul Alukal
[email protected]                                           Patrick J. LoPresti
[email protected]                                           Priscilla Ballou
[email protected]                                        Pierre Uszynski
[email protected]                                            Richard Ebling
[email protected]                                                       e. saxon
[email protected]                                         Richard R. Byrd
[email protected]                                                  Robert Loy
[email protected]                                  David Moore
[email protected]                                                      Shrisha Rao
[email protected]                                               Stanton Smith
[email protected]                                                  Dwight Brown
[email protected]                                                  Thomas Wagner
[email protected]                                    Silke-Maria  Weineck
[email protected]                                                 Ned Fleming
[email protected]                                                       Jean

Abstained
------------------------------------------------------------------------------
[email protected]                                                     Dan Rothschild
[email protected]                                             Edna Campos


Votes in error
------------------------------------------------------------------------------
[email protected]                                                 Harry Bradley
   ! Invalid address
[email protected]                                                      Cognitee
   ! No vote statement in message

-- 
Jani Patokallio <[email protected]>
Voting address: <[email protected]>
 
USENET FACT: Big-8
BIG-8 hierarchies are the 8 traditional top hierarchies of the Usenet. See the following page for more